Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Renalytix Ai Plc ADR
(NQ:
RNLX
)
0.3400
+0.0170 (+5.26%)
Streaming Delayed Price
Updated: 3:57 PM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Renalytix Ai Plc ADR
< Previous
1
2
3
4
5
6
7
8
Next >
Markets Turn Bullish After Dow Rises For Third Straight Session
June 09, 2023
The CNN Money Fear and Greed index showed an improvement in overall sentiment among U.S. investors on Thursday. U.S. stocks closed higher on Thursday following the release of initial jobless claims...
Via
Benzinga
Earnings Preview For Renalytix
June 08, 2023
Via
Benzinga
Renalytix to Report Third Quarter Fiscal Year 2023 Financial Results on June 9
June 05, 2023
From
Renalytix plc
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 30, 2023
It's time for a look at the biggest pre-market stock movers on Tuesday morning with all the details traders need to know about!
Via
InvestorPlace
Renalytix AI Earnings Preview
March 29, 2023
Via
Benzinga
Preview: Renalytix AI's Earnings
November 29, 2022
Via
Benzinga
Renalytix selects EVERSANA® to expand commercialization of KidneyIntelX for Early-Stage Kidney Disease Prognosis Detection in Patients with Type 2 Diabetes
May 25, 2023
Model expected to accelerate deployment of KidneyIntelX across key U.S. regions with high rates of diabetic kidney disease and established insurance coverage
From
Renalytix plc
Via
GlobeNewswire
New Published Real-World Evidence Shows KidneyIntelX™ Utility
April 19, 2023
From
Renalytix plc
Via
GlobeNewswire
Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting
April 12, 2023
From
Renalytix plc
Via
GlobeNewswire
Earnings Scheduled For March 30, 2023
March 30, 2023
Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is estimated to report quarterly loss at $0.12 per share on revenue of $10.80 million.
Via
Benzinga
Renalytix Reports Second Quarter and First Half Fiscal Year 2023 Financial Results
March 30, 2023
From
Renalytix plc
Via
GlobeNewswire
Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30
March 22, 2023
From
Renalytix plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
March 13, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 03, 2023
Via
Benzinga
Renalytix to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
February 09, 2023
From
Renalytix plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
February 08, 2023
Via
Benzinga
Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket
February 08, 2023
Gainers PainReform Ltd. (NASDAQ: PRFX) shares rose 89.5% to $0.9475 in pre-market trading. PainReform reported receipt of extension to Aug. 7, 2023 to meet the Nasdaq's minimum bid price requirement.
Via
Benzinga
Renalytix announces a c.$20.3 million private placement
February 08, 2023
From
Renalytix plc
Via
GlobeNewswire
Renalytix and Partners Awarded $10 Million Horizon Europe Grant to Advance Personalized Medicine in Treating CKD Throughout Europe and the United States
January 26, 2023
Award for consortium of industry, academic and clinical research leaders to develop personalized drug response tests in chronic kidney disease
From
Renalytix plc
Via
GlobeNewswire
Renalytix Completes Agreement with Veterans Administration to Integrate KidneyIntelX Testing across all Electronic Health Record systems
January 09, 2023
Significant milestone will make KidneyIntelX accessible to 960,000 veterans with chronic kidney disease
From
Renalytix AI, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
December 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 19, 2022
Via
Benzinga
Primary Care Use of KidneyIntelX in Early Stage CKD Improved Clinical Care Delivery and Outcomes
December 01, 2022
First-in-class bioprognostic™ KidneyIntelX provided clear direction for primary care physicians to slow or stop progression of chronic kidney disease in adult diabetes patients
From
Renalytix AI, Inc.
Via
GlobeNewswire
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2023
November 30, 2022
From
Renalytix AI, Inc.
Via
GlobeNewswire
Earnings Scheduled For November 30, 2022
November 30, 2022
Companies Reporting Before The Bell • Seadrill (NYSE:SDRL) is expected to report earnings for its third quarter. • Build-A-Bear Workshop (NYSE:BBW) is likely to report earnings for its third quarter.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 29, 2022
Via
Benzinga
Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease
November 29, 2022
From
Renalytix AI, Inc.
Via
GlobeNewswire
Renalytix to Report Financial Results for First Quarter Fiscal Year 2023 on November 30
November 22, 2022
From
Renalytix plc
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 16, 2022
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.